SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-027629
Filing Date
2017-02-01
Accepted
2017-02-01 17:18:04
Documents
7
Period of Report
2017-01-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d280001d8k.htm 8-K 21565
2 EX-10.1 d280001dex101.htm EX-10.1 19091
3 EX-99.1 d280001dex991.htm EX-99.1 8446
4 GRAPHIC g280001g33x38.jpg GRAPHIC 2331
5 GRAPHIC g280001g35h27.jpg GRAPHIC 3944
6 GRAPHIC g280001g56d46.jpg GRAPHIC 2383
7 GRAPHIC g280001g72n65.jpg GRAPHIC 2335
  Complete submission text file 0001193125-17-027629.txt   66063
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37609 | Film No.: 17565842
SIC: 2834 Pharmaceutical Preparations